Interactive Strength Inc. (NASDAQ:TRNR) Wins New Customer for CLMBR with Fast-growing 60 Location Chuze Fitness

October 10, 2024 7:00 AM

Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that Chuze Fitness has ordered multiple CLMBRs to install in four pilot locations out of the brand's 60 total locations.Trent Ward, Co-Founder and CEO of TRNR, said: "Chuze is one of the fastest growing health club chains in the US, having grown from 44 locations to 60 locations over...

Read more

NHI Issues Investor Update

October 10, 2024 5:30 AM

National Health Investors, Inc. (NYSE:NHI) has issued an investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's...

Read more

AlzeCure Pharma Broadcasts Live Event About the Phase II Candidate ACD440 Against Neuropathic Pain

October 10, 2024 4:20 AM

STOCKHOLM, SE / ACCESSWIRE / October 10, 2024 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company arranges a live event on October 23 at 1 p.m. with Dr. Rolf Karlsten as invited guest speaker.During the symposium, titled "ACD440 - A novel...

Read more

AGC Biologics Begins Operations at New State-of-the-Art Manufacturing Building in Copenhagen after Successful Inspection and Licensing from Danish Medicines Agency

October 10, 2024 4:00 AM

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today the successful completion of the final milestone at its new manufacturing building at its Copenhagen site. The site received authorization and a license to begin production from the Danish Medicines Agency for its new four-story 19,000 m² manufacturing building in September, allowing it to begin official operations.AGC...

Read more

Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024

October 10, 2024 1:20 AM

Financial HighlightsDirect MagnetOsTM sales rose by 149% to CHF 50.6 million in the first nine months of 2024, from CHF 20.4 million in the same period in 2023Total Kuros Medical Devices segment sales accelerated to CHF 51.1 million in Q3 2024 from CHF 21.3 million in Q3 2023 year to dateKuros Medical Devices segment EBITDA increased to CHF 13.3 million in the first nine months compared to CHF 3.8 million in the same period in 2023, representing...

Read more

Cantargia’s Strong Phase 2 Clinical Data in Pancreatic Cancer with Nadunolimab Published in Clinical Cancer Research

October 10, 2024 1:20 AM

LUND, SWEDEN / ACCESSWIRE / October 10, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced the publication of the results using nadunolimab (CAN04) combination therapy in advanced/metastatic pancreatic cancer (PDAC) in the scientific journal Clinical Cancer Research, a journal of the American Association for Cancer Research. Efficacy in the 73 patients treated was better than expected for chemotherapy...

Read more

Formula Wellness Appoints Michael Bennett as Chief Executive Officer, Paving the Way for Expansion and Innovation

October 9, 2024 7:15 PM

DALLAS, TX / ACCESSWIRE / October 9, 2024 / Formula Wellness, a leading innovator in personalized wellness and aesthetics, proudly announces the appointment of Michael Bennett as its new Chief Executive Officer. With a distinguished career spanning over two decades in the healthcare industry, Bennett brings a proven track record of driving transformational growth, building strategic partnerships, and elevating patient-centric care.Bennett joins...

Read more

Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024

October 9, 2024 4:05 PM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2024 financial results after market close on Wednesday, October 30, 2024. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.Conference Call...

Read more

Nicole Garrett's Under Pressure Hyperbarics Partners With L.A. Fashion Weekend to Elevate the Health and Wellness Component

October 9, 2024 3:30 PM

Introducing Cutting-Edge Wellness Experiences to the Heart of LA's Fashion SceneLOS ANGELES, CA / ACCESSWIRE / October 9, 2024 / This year, Under Pressure Hyperbarics, led by renowned hyperbaric technologist Nicole Garrett, CHT, will partner with Los Angeles Fashion Weekend (L.A.Fashion Weekend) to bring a new dimension of wellness to the event. On Saturday, October 12th, from 12:00-3:00 p.m., Garrett and her team will offer a unique opportunity...

Read more

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy

October 9, 2024 2:00 PM

NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation of advanced oral drug delivery systems, announced today its attendance at the Convention on Pharmaceutical Ingredients (CPHI Global) from October 8-10, 2024 in Milan, Italy. The event brings together the global pharmaceutical community to explore the latest innovations in drug manufacturing, packaging, and...

Read more

Parcel Health(R) Offers Safer, Sustainable Paper Pill Bottles for Affordable Obesity Treatment

October 9, 2024 1:15 PM

Parcel Health aims to continue to provide sustainable paper pill bottles to divert plastic from the waste stream and help to provide affordable and safe delivery of treatments for obesity.PITTSBURGH, PA / ACCESSWIRE / October 9, 2024 / The recent resolution of the shortage of a prominent anti-obesity drug highlights the ongoing challenges of accessibility and affordability in obesity treatment. This article analyzes the business strategies and...

Read more

Everything Seniors Should Know About Root Canal Treatments

October 9, 2024 12:00 PM

Root canal treatments are a tooth-saving procedure that can help seniors save damaged teeth. However, after age 65, it's important for seniors to weigh the root canal cost against the benefits. While a root canal can save a tooth, there may be other options for older adults to consider, like dentures and implants, that will better serve oral health as they age. Before committing to a root canal procedure, here are five things for seniors to...

Read more

Centaur Labs Secures $16M in Series B Funding to Help Health and Scientific Organizations Accelerate AI Development

October 9, 2024 12:00 PM

BOSTON, MA / ACCESSWIRE / October 9, 2024 / Centaur Labs, a leader in health data annotation, today announced the successful completion of a $16M+ oversubscribed Series B funding round led by SignalFire, with additional participation from Matrix, Susa Ventures and new investors Samsung Next and Alumni Ventures. In addition, Centaur Labs launched its on-demand AI data labeling product, which enables AI developers to collect labels from experts in...

Read more

Smile Digital Health Joins NCQA’s Digital Content Services Early Adopters Program to Support the Digitization of HEDIS Scores

October 9, 2024 10:30 AM

Smile Digital Health is contributing insights and best practices for the digitization of HEDIS® scores as part of the NCQA Digital Content Services Early Adopters Program.TORONTO, ON / ACCESSWIRE / October 9, 2024 / Smile Digital Health (Smile), a leading Fast Healthcare Interoperability Resources (FHIR®) health data platform and exchange solutions provider, is proud to announce its participation in the National Committee for Quality Assurance...

Read more

United States Phlebotomy Equipment Industry to Cross USD 5.8 Billion Mark by 2034 Amid Growing Demand for Blood Tests | Future Market Insights

October 9, 2024 9:30 AM

As per latest analysis, the United States phlebotomy equipment industry is set to be valued at USD 4.2 billion in 2024. Overall sales of phlebotomy equipment in the nation will likely rise at 3.3% CAGR during the forecast period, totaling USD 5.8 billion by 2034.Demand for phlebotomy supplies is expected to grow at a higher CAGR of 3.9% during the forecast period. This is due to their indispensable role in facilitating safe, efficient, and...

Read more

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing

October 9, 2024 9:05 AM

KELOWNA, BC / ACCESSWIRE / October 9, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that dosing has begun, for human pilot study #3 (the "Study"), investigating a DehydraTECH-processed version of the dual action GLP-1 (glucagon-like peptide) + GIP (glucose-dependent insulinotropic peptide) Zepbound® (tirzepatide) in an oral dose...

Read more

Hurricane Helene and Milton Devastation: Supporting Impacted Healthcare Professionals and Medical Facilities

October 9, 2024 9:00 AM

OMAHA, NE / ACCESSWIRE / October 9, 2024 / As a company focused on supporting healthcare professionals, medical facilities, and patients, Fusion is saddened by the devastation and crisis caused by Hurricanes Helene and Milton. To provide resources to those best equipped to support those in need, Fusion has provided a financial gift to the American Red Cross and is providing direct support to its impacted traveling healthcare professionals and...

Read more

MedCana Highlights Recent Acquisitions and the Multiple Cannabis Licenses Associated with Each

October 9, 2024 9:00 AM

MedCana (OTC PINK:SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, proudly announces significant and multiple acquisitions, along with multiple cannabis licenses associated with each, bolstering the company's cannabis portfolio globally.With these recent acquisitions, MedCana has rapidly solidified its position as a leading force in the Cannabis industry. Due to the large number of...

Read more

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector

October 9, 2024 8:30 AM

PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is pleased to announce that it has received confirmation from Nasdaq that the Company has officially regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2,500,000. With this important achievement, the Company can now fully focus on developing its newly announced iGaming business,...

Read more

Growing Something Greater in Secaucus, NJ

October 9, 2024 8:30 AM

NORTHAMPTON, MA / ACCESSWIRE / October 9, 2024 / Quest Diagnostics Quest celebrates collaboration with Green Bronx Machine and unveils Tower Garden in Secaucus HQQuest recently hosted a lunch-and-learn event at our Secaucus headquarters to hear from Stephen Ritz, founder of Green Bronx Machine (GBM). GBM is doing transformational work to advance health equity in under-resourced communities by growing vegetables in schools-and Quest is lending...

Read more